Matej Mikulic
Research expert covering health, pharma & medtech
Health regulations in the U.S. - Statistics & Facts
Health regulations in the United States serve as the primary safeguard for public safety, dictating how medical products are manufactured, labeled, and distributed. What distinguishes the U.S. is its unmatched commercial scale combined with a rigorous, highly centralized oversight model. The U.S. represents the single largest national pharmaceutical market in the world, accounting for more than half of the total global prescription drug market. The extreme financial stakes in this sector are illustrated by top-selling branded prescription drugs, where the leading clinical oncology drug, Keytruda, alone generated 18 billion U.S. dollars in U.S. sales in 2025. This extraordinary concentration of capital is governed by strict federal standards designed to prevent corporate corner-cutting while ensuring that the public can trust the safety and efficacy of commercial therapies. Because non-compliance can halt multi-million-dollar product lines overnight, navigating these rules is a core strategic priority for any pharmaceutical company.
